PortfoliosLab logo
GHM vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GHM and LLY is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

GHM vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Graham Corporation (GHM) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

GHM:

0.83

LLY:

-0.27

Sortino Ratio

GHM:

1.22

LLY:

-0.11

Omega Ratio

GHM:

1.16

LLY:

0.99

Calmar Ratio

GHM:

0.72

LLY:

-0.39

Martin Ratio

GHM:

1.67

LLY:

-0.73

Ulcer Index

GHM:

20.06%

LLY:

13.53%

Daily Std Dev

GHM:

53.33%

LLY:

38.44%

Max Drawdown

GHM:

-86.10%

LLY:

-68.27%

Current Drawdown

GHM:

-20.96%

LLY:

-24.32%

Fundamentals

Market Cap

GHM:

$444.51M

LLY:

$651.06B

EPS

GHM:

$0.81

LLY:

$12.30

PE Ratio

GHM:

49.11

LLY:

58.49

PEG Ratio

GHM:

0.77

LLY:

1.10

PS Ratio

GHM:

2.23

LLY:

13.29

PB Ratio

GHM:

3.79

LLY:

40.97

Total Revenue (TTM)

GHM:

$150.55M

LLY:

$49.00B

Gross Profit (TTM)

GHM:

$36.42M

LLY:

$40.03B

EBITDA (TTM)

GHM:

$13.95M

LLY:

$16.27B

Returns By Period

In the year-to-date period, GHM achieves a -11.63% return, which is significantly lower than LLY's -6.05% return. Over the past 10 years, GHM has underperformed LLY with an annualized return of 7.67%, while LLY has yielded a comparatively higher 27.04% annualized return.


GHM

YTD

-11.63%

1M

28.94%

6M

-10.31%

1Y

43.69%

3Y*

75.10%

5Y*

29.44%

10Y*

7.67%

LLY

YTD

-6.05%

1M

-18.20%

6M

-7.98%

1Y

-10.35%

3Y*

31.86%

5Y*

38.02%

10Y*

27.04%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Graham Corporation

Eli Lilly and Company

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

GHM vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GHM
The Risk-Adjusted Performance Rank of GHM is 7373
Overall Rank
The Sharpe Ratio Rank of GHM is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of GHM is 7070
Sortino Ratio Rank
The Omega Ratio Rank of GHM is 6969
Omega Ratio Rank
The Calmar Ratio Rank of GHM is 7878
Calmar Ratio Rank
The Martin Ratio Rank of GHM is 7070
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 3232
Overall Rank
The Sharpe Ratio Rank of LLY is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 3232
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 3232
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 2525
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 3434
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GHM vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Graham Corporation (GHM) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current GHM Sharpe Ratio is 0.83, which is higher than the LLY Sharpe Ratio of -0.27. The chart below compares the historical Sharpe Ratios of GHM and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

GHM vs. LLY - Dividend Comparison

GHM has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.78%.


TTM20242023202220212020201920182017201620152014
GHM
Graham Corporation
0.00%0.00%0.00%0.00%3.54%2.90%1.92%1.66%1.72%1.63%1.90%0.56%
LLY
Eli Lilly and Company
0.78%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

GHM vs. LLY - Drawdown Comparison

The maximum GHM drawdown since its inception was -86.10%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for GHM and LLY.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

GHM vs. LLY - Volatility Comparison

The current volatility for Graham Corporation (GHM) is 14.00%, while Eli Lilly and Company (LLY) has a volatility of 16.54%. This indicates that GHM experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

GHM vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Graham Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
47.04M
12.73B
(GHM) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

GHM vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Graham Corporation and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20212022202320242025
24.8%
82.5%
(GHM) Gross Margin
(LLY) Gross Margin
GHM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Graham Corporation reported a gross profit of 11.69M and revenue of 47.04M. Therefore, the gross margin over that period was 24.8%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.

GHM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Graham Corporation reported an operating income of 2.21M and revenue of 47.04M, resulting in an operating margin of 4.7%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.

GHM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Graham Corporation reported a net income of 1.59M and revenue of 47.04M, resulting in a net margin of 3.4%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.